Literally over here, working my ass off.. #tirzepatide #mounjaro

#Tirzepatide #Peptide #EIM #Wellness #Benefits

AI analysis of social media posts reveals potential side effects of GLP-1 meds that researchers say may not be fully captured in clinical trials.
youtu.be/1h-dr9VBs20

#semaglutide #tirzepatide #ozempic #mounjaro #wegovy #zepbound #GLP1 #GLP1drugs

Genetics may influence the effectiveness of weight loss drugs, study finds Variations in two genes involved in gut hormone pathways, which regulate appetite and digestion, may help to explain different weight-loss outcomes or side effects when taking GLP-1 medicines, a new…

🧬 Genetics may influence the effectiveness of weight loss drugs, study finds 🧬

Read the full story here: buff.ly/QXFMsqx

#GLP1 #weightloss #genetics #semaglutide #tirzepatide #efficacy #outcomes

Tirzepatide boosts ixekizumab benefits in patients with PsA and obesity Combining ixekizumab with tirzepatide offers additive clinical benefits over ixekizumab alone in the treatment of psoriatic arthritis in patients with overweight or obesity.

#MedNews - Combining #ixekizumab with #tirzepatide offers additive clinical benefits over ixekizumab alone in the treatment of psoriatic #arthritis in patients with overweight or obesity.

Full story 👉 buff.ly/W3uyUrY

#RheumSky

Mounjaro Use Rises in India Before Weddings Investing.com (Apr 3, 2026) reports rising pre-wedding Mounjaro use in India; tirzepatide showed ~17–22% mean weight loss in SURMOUNT-1 (NEJM, 2022).

Mounjaro Use Rises in India Before Weddings: Investing.com (Apr 3, 2026) reports rising pre-wedding Mounjaro use in India; tirzepatide showed ~17–22% mean weight loss in SURMOUNT-1 (NEJM, 2022). 👈 Read full analysis #Mounjaro #Tirzepatide #WeightLoss #PreWedding #India

Eli Lilly Launches Zepbound KwikPen on Ro Eli Lilly added Zepbound KwikPen to Ro on Apr 2, 2026; the tirzepatide pen (FDA approved Nov 17, 2023) expands telehealth distribution and tests payer adjudication.

Eli Lilly Launches Zepbound KwikPen on Ro: Eli Lilly added Zepbound KwikPen to Ro on Apr 2, 2026; the tirzepatide pen (FDA approved Nov 17, 2023) expands telehealth distribution and tests payer adjudication. 👈 Read full analysis #EliLilly #Zepbound #KwikPen #Tirzepatide #Telehealth

The Disappearing Benefits of GLP-1 Drugs The weight-loss and heart benefits of GLP-1 RA drugs like Ozempic build over time. They also fade if the medication is stopped.

The Disappearing Benefits of GLP-1 Drugs
The weight-loss and heart benefits of GLP-1 RA drugs like Ozempic build over time. They also fade if the medication is stopped. www.thedoctorwillseeyounow.com/content/hear... @bmjmedicine.bsky.social #cardio #zepbound #tirzepatide #semaglutide #cvd #GLP

JAMA Cardiology RCT shows cardiorenal outcomes with tirzepatide vs. dulaglutide in diabetes/cardiovascular disease patients. Population: 9348 male, 3817 female. Intervention: 13299 randomized. Graph compares cumulative incidence of both.

In patients w/ type 2 #diabetes and #cardiovascular disease, the dual #GLP1/glucose-dependent insulinotropic polypeptide agonist #tirzepatide was associated w/ a lower incidence of major cardiorenal events compared with dulaglutide.

#ACC26 @accintouch.bsky.social

ja.ma/4s1pCfZ

Three graphs titled SURMOUNT-1, SURMOUNT-3, and SURMOUNT-4 show the change from baseline in body weight (%) over time (weeks). Each graph plots multiple lines representing different treatment groups, including placebo and varying doses of tirzepatide MTD.

In three RCTs, #Tirzepatide was associated with clinically meaningful weight loss among adults with overweight or obesity, even when concomitant weight-inducing medications were initiated during treatment.

ja.ma/4uZZyVo

0/10 recommend waiting to fill your script with your doc on tirzepatide until after you meet with them...basically took a week and some change off of the meds and now feel a deep unsettling in the stomach parts constantly.

#weightloss #tirzepatide #mounjaro #chunky #tummy #rumbles

Postmenopausal Women Lose Significantly More Weight When Combining Hormone Therapy with Tirzepatide A recent Mayo Clinic study has found that postmenopausal women who combined menopausal hormone therapy with tirzepatide, a medication approved for overweight and obesity, lost approximately 35% more weight than those taking the drug alone. The study analyzed 120 adults treated with tirzepatide for at least 12 months, comparing outcomes between those using hormone therapy and those who were not. While the study was observational and not randomized, suggesting that other factors like lifestyle or improved sleep may contribute, researchers noted the results indicate a potential synergy between estrogen and GLP-1-based medications. Estrogen may enhance the appetite-suppressing effects of drugs like tirzepatide, opening new possibilities for more effective and personalized approaches to weight management in postmenopausal women. Future research will focus on confirming these results through randomized clinical trials and exploring additional cardiometabolic benefits. This work highlights the importance of considering both hormone therapy and obesity medications in strategies aimed at reducing cardiovascular and metabolic risks after menopause.

Postmenopausal Women Lose Significantly More Weight When Combining Hormone Therapy with Tirzepatide

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

#menopause #tirzepatide #hormonetherapy

View full AI summary:

The Risks of Buying GLP-1 Weight Loss Drugs Online Why physician supervision and trusted GLP-1 medication sourcing matter when using semaglutide or tirzepatide GLP-1 medications such as semaglut...

#Blog #Post #Dr. #Sowemimo #GLP-1 #GLP-1 #doctor #NJ […]

[Original post on primesurgicare.com]

exacerbation-of-depression-with-tirzepatide-mounjaro Das arznei-telegramm informiert - unabhängig. kritisch. anzeigenfrei.

CURRENT ADR NETWORK REPORT

Exacerbation of #Depression in a Patient Receiving Treatment with #Tirzepatide (Mounjaro)

Article freely available
#OpenAccess

www.arznei-telegramm.com/en/294/exace...

Colourful i-Base graphic. The main text reads: GLP-1 agonists like Ozempic might help people beat drug addiction. At the top is i-Base’s website address: I hyphen base dot info. A smaller rectangle in the bottom right, reads: HIV news. 2026. There are various dotted patterns. The colours used in the image are two shades of khaki green, dark purple, light blue, blue, pink, turquoise, orange, dark green, mustard and white.

New paper in @bmj.com shows GLP-1 receptor agonists can tackle #SubstanceUseDisorder:

i-base.info/htb/53421

Could they also help to break #chemsex addiction?

#HIVsky #GUMsky #HIV #PLWH #PWH #HIVpositive #GLP1s #GLP1ReceptorAgonists #Ozempic #Wegovy #Mounjaro #semaglutide #tirzepatide #addiction

Everything you need to know about GLP-1s for weight loss Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as “breakthrough” drugs in 2023 — and their popularity has soared since.  Around 2.5 million people each month accessed GLP-1s privately…

*Everything you need to know about GLP-1s for weight loss*

From #semaglutide to #tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use

#GLP1s #weightloss #obesity #diabetes

MSN

#ozempic #semaglutide #weightloss #weightlossjourney #ozempicweightloss #wegovy #mounjaro #semaglutide #ozempicweightloss #wegovy #mounjaro #tirzepatide #weightloss #weightlossjourney #ozempicbaby #ozempicface #ozempicjourney
www.youtube.com/shorts/9fj65...
www.msn.com/en-ca/health...

💉 GLP-1RAs are now famous for their weight loss capabilities, but a new review suggests that the rebound weight people gain after stopping the medication is real, though you might not regain all of the weight back

buff.ly/acx9bnP

#science #GLP1 #ozempic #wegovy #semaglutide #tirzepatide

Almost 2,000 unauthorised weight loss drugs seized in MHRA raids Almost 2,000 doses of unauthorised weight loss drugs have been seized following raids on two properties, the UK medicines watchdog has said.

Almost 2,000 unauthorised weight loss drugs seized in MHRA raids.

buff.ly/377TMQx

#weightloss #weightlossdrugs #mounjaro #tirzepatide #mhra #medicines

Almost 2,000 unauthorised weight loss drugs seized in MHRA raids Almost 2,000 doses of unauthorised weight loss drugs have been seized following raids on two properties, the UK medicines watchdog has said.

Dr Zubir Ahmed, Health Innovation and Patient Safety Minister, has urged people to not buy weight loss medicines from unregulated sources.

buff.ly/9OUubnt

#weightloss #weightlossdrugs #mounjaro #tirzepatide #mhra #medicines

Curious whether Mounjaro is right for you? This video explains how tirzepatide works, who qualifies in the UK, and what to know before considering treatment. Watch now www.youtube.com/shorts/w8TuR...
#mounjaro #weightloss #peptides #tirzepatide #propepsciences #mounjarouk #tirzepatideuk #uk #london

Researchers discover how an anti-obesity drug improves metabolism beyond weight loss - IBUB - Institut de Biomedicina de la Universitat de Barcelona Tirzepatide is one of the drugs that has revolutionized the treatment of obesity and other conditions such as diabetes in recent years. Despite its clinical success, its precise molecular and cellular...

“This drug not only reduces body weight, but also has beneficial effects on metabolism.”

#Tirzepatide #Mounjaro #Zepbound

www.ub.edu/ibub/researc...

Toplines from a non-inferiority trial of #CagriSema vs #tirzepatide were another tough break for @novonordisk.bsky.social yesterday. We will have to wait and see what the true clinical value for this combination therapy will be. But it's unlikely to be a home run.
conscienhealth.org/2026/02/24/c...

NICE confirms expanded access to GLP-1s for people with type 2 diabetes In guidance published today, NICE recommends expanded access to GLP-1 receptor agonists and tirzepatide for people with type 2 diabetes.

NICE confirms expanded access to GLP-1s for people with type 2 diabetes

buff.ly/1d8mRBj

#diabetes #weightloss #semaglutide #tirzepatide #NICE #type2diabetes #pharmacy

Insulinoma Unmasked By Tirzepatide: A Rare Case of Postprandial Hypoglycemia In a Nondiabetic Patient Abstract. A 63-year-old woman with obesity presented with severe postprandial hypoglycemia that worsened after starting tirzepatide for weight loss. Furthe

Insulinoma Unmasked By Tirzepatide: A Rare Case of Postprandial Hypoglycemia In a Nondiabetic Patient. Read more in #JCEMCaseReports: bit.ly/4ta09mr #insulinoma #Tirzepatide #NeuroendocrineTumor @endocrinesociety.bsky.social

Cover of February 2026 issue of The Lancet Obstetrics, Gynaecology, & Women's Health. A women walks on a footpath towards a sunset, leaving a trail of red poppies behind

Our February issue is now live!

📚https://www.thelancet.com/issue/S3050-5038(26)X2001-5

We have original research & review content on #menstrual #bleeding & #postpartum #haemorrhage, #MHT modulation of #tirzepatide associated weight loss, and interventions after after #hypertensive #pregnancy.

Tirzepatide may protect against diabetic retinopathy Tirzepatide reduces the risk for, and progression of diabetic retinopathy compared with lifestyle intervention alone.

#MedNews - #Tirzepatide reduces the risk for, and progression of diabetic #retinopathy compared with lifestyle intervention alone.

Full story 👉 buff.ly/mi2NUYK

#EyeSky #Diabetes